These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Risk of malignancy associated with diagnostic categories of the proposed World Health Organization International System for Reporting Pancreaticobiliary Cytopathology. Hoda RS, Arpin RN, Rosenbaum MW, Pitman MB. Cancer Cytopathol; 2022 Mar; 130(3):195-201. PubMed ID: 34623767 [Abstract] [Full Text] [Related]
5. The World Health Organization Reporting System for Pancreaticobiliary Cytopathology: Overview and Summary. Centeno BA, Saieg M, Siddiqui MT, Perez-Machado M, Layfield LJ, Weynand B, Reid MD, Stelow EB, Lozano MD, Fukushima N, Cree IA, Mehrotra R, Schmitt FC, Field AS, Pitman MB. Cancer Cytopathol; 2024 Jul; 132(7):396-418. PubMed ID: 38709670 [Abstract] [Full Text] [Related]
9. Risk of malignancy associated with the diagnostic categories proposed by the Papanicolaou Society of Cytopathology for pancreaticobiliary specimens: An institutional experience. Gonzalez-Mancera MS, Ahmadian SS, Gomez-Fernandez C, Velez-Torres J, Jorda M, García-Buitrago MT. Diagn Cytopathol; 2022 Feb; 50(2):49-56. PubMed ID: 34856075 [Abstract] [Full Text] [Related]
11. The WHO system versus the Papanicolaou society of cytopathology system for reporting pancreaticobiliary cytology for risk stratification-which is better? Kundu R, Kollabathula A, Gupta N, Rohilla M, Rana SS, Nada R, Kalra N, Basher RK, Gupta P, Dey P, Gupta R, Dutta U, Srinivasan R. Diagn Cytopathol; 2024 Mar; 52(3):145-155. PubMed ID: 38059418 [Abstract] [Full Text] [Related]
13. Diagnostic Performance of Pancreatic Cytology with the Papanicolaou Society of Cytopathology System: A Systematic Review, before Shifting into the Upcoming WHO International System. Nikas IP, Proctor T, Seide S, Chatziioannou SS, Reynolds JP, Ntourakis D. Int J Mol Sci; 2022 Jan 31; 23(3):. PubMed ID: 35163571 [Abstract] [Full Text] [Related]
15. A brief review of the WHO reporting system for pancreaticobiliary cytopathology. Pitman MB, Centeno BA, Reid MD, Saeig M, Siddiqui MT, Layfield LJ, Perez-Machado M, Weynand B, Stelow EB, Lozano MD, Fukushima N, Cree IA, Mehrotra R, Schmitt FC, Field AS. J Am Soc Cytopathol; 2023 Jan 31; 12(4):243-250. PubMed ID: 37003924 [Abstract] [Full Text] [Related]
17. The World Health Organization classification of pancreaticobiliary cytopathology stratifies risk of malignancy and outcome for endoscopic ultrasound-guided fine-needle aspiration of the pancreas. Lui SK, Hargett I, Pharaa Z, Aviles M, Botelho S, Feliciano DL, Kim V, Sigel K, Armstrong M, Wilson CE, Shah P, Soares K, Sigel C. Cancer Cytopathol; 2023 Dec 31; 131(12):762-771. PubMed ID: 37602886 [Abstract] [Full Text] [Related]
18. Guidelines for pancreaticobiliary cytology from the Papanicolaou Society of Cytopathology: A review. Pitman MB, Layfield LJ. Cancer Cytopathol; 2014 Jun 31; 122(6):399-411. PubMed ID: 24777782 [Abstract] [Full Text] [Related]
19. Cytologic categorization of pancreatic neoplastic mucinous cysts with an assessment of the risk of malignancy: A retrospective study based on the Papanicolaou Society of Cytopathology guidelines. Smith AL, Abdul-Karim FW, Goyal A. Cancer Cytopathol; 2016 Apr 31; 124(4):285-93. PubMed ID: 26618476 [Abstract] [Full Text] [Related]